Antineoplastic effects of mammalian target of rapamycine inhibitors

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

484

HTML

4143

Figures (1-4)

476

Tables (1-3)

227

Sum=5330

Oct 24, 2012 (publication date) through Dec 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Oct 24, 2012; 2(5): 74-83
Published online Oct 24, 2012. doi: 10.5500/wjt.v2.i5.74

Table 2 Viruses linked to malignancies

Virus	Malignancy
EBV	Lymphoma (PTLD)
HHV-8	Kaposi’s sarcoma
HPV	Cervical, vulvar cancer
HPV-58	Bowen disease
HPV 8, 19	Non melanoma skin cancer
HPV 16, 20	Skin and tonsillar carcinoma
HCV, HBV	Hepatocellular carcinoma

EBV: Epstein-Barr virus; HHV: Human herpesvirus; HPV: Human papillomavirus; HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Citation: Salvadori M. Antineoplastic effects of mammalian target of rapamycine inhibitors. World J Transplant 2012; 2(5): 74-83
URL: https://www.wjgnet.com/2220-3230/full/v2/i5/74.htm
DOI: https://dx.doi.org/10.5500/wjt.v2.i5.74